The 19th edition of BioAsia, the annual flagship event of the government of Telangana will be held from 24th to 25th February, 2022 in a virtual format. The theme of this year’s edition is ‘Future Ready’ and would focus on exploring the lifesciences industry’s current position and future potential, new approaches and capabilities required to be ready as the lifesciences industry develops its future growth strategy. The future growth will be driven by a shift from “volume focus” to “volume + value focus.” The industry needs to continue building on its strength, and at the same time, make a giant leap towards innovation. New capabilities need to be introduced across the business functions to bring efficiencies and to help the industry move up the value chain, BioAsia said in a statement.
The event will bring together leaders from the industry, research, innovation and governments from over 70 countries to address the wide-ranging needs of the healthcare system. The conference will provide a unique opportunity to pharma and biotech companies, CROs, CMOs, CDMOs, biotech startups, academic institutions, scientists and researchers, policymakers and regulatory experts across the globe to assess the industry’s current position and deliberate on the imperatives for future growth and other insightful topics related to the lifesciences industry, the statement added.
It also said that the two-day event will witness a wide array of panels focussing on the future of the lifesciences amid the ongoing pandemic and the ways the industry must be focussing on to combat any future pandemics.
Unveiling the dates and theme of the event, KT Rama Rao, Minister for Industries and Commerce (I&C) and Information Technology (IT), government of Telangana, said, “Hyderabad has cemented its position as the lifesciences hub of the country and the vaccine capital of the world. BioAsia has been an integral part of this extraordinary growth story and the event continues to help us in showcasing the prowess of Hyderabad, in particular, and India, in general, to the world. I invite stakeholders from around the world to take an active part in the deliberations.”
Adding to it, Shakthi Nagappan, CEO, BioAsia, and Director, Life Sciences, GoTS, also said, “…….The 2021 event witnessed around 31,450 participants representing 72 countries with 60 high-profile speakers. We are confident that the 19th edition will bring together some of the most influential leaders to discuss about a wide range of topics concerning the opportunities and challenges in the healthcare sector.”